Alle patienter, uanset genotype, der har opnået serum HCV- RNA under målbar grænse i uge 12, bør modtage 48 ugers behandling.
All patients, irrespective of genotype, who have demonstrated serum HCV-RNA below the limits of detection at Week 12 should receive 48 weeks of therapy.